Electromed, Inc. is a medical device company focused on airway clearance therapy for patients with compromised pulmonary function. The company develops, manufactures, markets, and sells the SmartVest airway clearance system and related products that use high frequency chest wall oscillation (HFCWO) to help mobilize airway secretions. Its portfolio includes home-use therapy systems as well as products designed for acute care settings, serving patients with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Electromed also offers connected therapy solutions that support communication between patients and physicians and help monitor treatment use. Headquartered in New Prague, Minnesota, Electromed plays a specialized role in respiratory care by providing noninvasive airway management tools used by clinicians, patients, and healthcare providers in the United States and selected international markets.
Website500 Sixth Avenue NW
New Prague, MN, 56071
United States
What share of all stock conversation is about ELMD?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% 0 | 0% 0 | 0% 0 |
Of the messages about ELMD that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | 81.25% -18.75 | 96.39% +24.11 | ||
| Bearish | — | — | 18.75% new | 3.61% -24.11 |
Of the messages about ELMD that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | — | 50% | 43.18% | ||
| Earnings | — | — | 25% | 18.18% | ||
| Technical Analysis | — | — | 25% | 36.36% | ||
| Analysts | — | — | 0% | 2.27% | ||
| Controversies | — | — | 0% | 0% | ||
| Macro | — | — | 0% | 0% |
Of the messages about ELMD, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | — | 60% | 9.68% | ||
| Newcomers | — | — | 40% | 90.32% |
NEW PRAGUE, Minn., September 09, 2026--Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event
On August 25, Electromed (NASDAQ:ELMD) reported fiscal fourth-quarter results that extended a streak few small-cap medical device companies can claim: fifteen consecutive quarters of year-over-year revenue and profit growth. Net revenue hit a record $19.4 million, up 11.6% from a year earlier, and diluted earnings per share climbed to $0.39 from $0.25. Those headline numbers […]
After Electromed’s selloff, explore SmartVest growth drivers, underpenetrated bronchiectasis market, reimbursement outlook, and why the stock looks like a...
Tipranks Press Release.
Investors talking about ELMD also mention